We present a human immunodeficiency virus-infected patient with severe decompensated hepatitis C virus-related cirrhosis awaiting liver transplantation (LT) who received a 24-week course of interferon/ribavirin-free antiviral treatment with sofosbuvir and daclatasvir on a compassionate basis. Rapid viral suppression was associated with progressive improvement of his liver function tests. The patient achieved a sustained virological response and concomitant clinical improvement, which prompted removal from the LT list 12 weeks after the end of treatment.

作者：J, Llaneras；L, Castells；B, Santos；M, Crespo；T, Puig；J I, Esteban；R, Esteban

来源：Transplant infectious disease : an official journal of the Transplantation Society 2016 年 18卷 3期